Pictet Asset Management’s Verona Pharma VRNA Stock Holding History

Pictet Asset Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-74,656	Closed	-$7.96M	–	2129
2025 Q3	$7.96M	Sell	74,656 -599,400	-89%	-$62.6M	0.01%	720
2025 Q2	$63.7M	Sell	674,056 -29,007	-4%	-$2.15M	0.06%	277
2025 Q1	$44.6M	Buy	+703,063	New	+$42.1M	0.05%	324

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Pictet Asset Management's VRNA Position: Q4 2025 in Review

Pictet Asset Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 74,656 shares — an estimated $7.96M sold.

Pictet Asset Management first reported a position in VRNA in Q1 2025 and held it in 3 quarters. The position peaked at $63.7M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Pictet Asset Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Pictet Asset Management sold 74,656 Verona Pharma shares in Q4 2025, an estimated $7.96M.
Pictet Asset Management first reported a position in Verona Pharma in Q1 2025 and held it in 3 quarters.
Pictet Asset Management's Verona Pharma position peaked at $63.7M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Pictet Asset Management's 13F filing for Q4 2025, filed 29 Jan 2026.